Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3/5
GC Biopharma Corp (006280 KS)
Watchlist
101
Analysis
Health Care
•
South Korea
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. It manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
LG Energy Solution
•
02 Mar 2022 07:56
KRX New Deal Index Rebalance: No Surprises as LG Chem Not Deleted from Battery Index
There is one change each for the Secondary Battery, Bio and Game Index. There are three changes to the Internet Index. LG Chem has not been deleted...
Brian Freitas
Follow
483 Views
Share
bearish
•
Douzone Bizon
•
27 Feb 2022 17:06
KRX K-New Deal Rebalancing: Latest Weight/Flow Update & LG Chem's Complete Deletion
This post provides the latest update on the weight adjustments and flow estimations for the KRX K-New Deal Index rebalancing.
Sanghyun Park
Follow
406 Views
Share
bullish
•
Hotel Shilla
•
09 Feb 2022 07:24
KOSPI Size Index Series Rebalancing Screening Results
This post has the screening results of the KOSPI Size Index Series rebalancing: 14 new MidCap entrants are expected to have a sizable passive impact.
Sanghyun Park
Follow
338 Views
Share
bullish
•
LG Energy Solution
•
02 Feb 2022 10:57
KRX New Deal Index Rebalance Preview (March): More Flow for LG Energy
There are many changes to the KRX New Deal indices at the March rebal. The largest inflow is on LG Energy. The largest buying impact is on...
Brian Freitas
Follow
425 Views
Share
bullish
•
GC Biopharma Corp
•
15 Jan 2022 15:01
Green Cross (006280 KS): Look Ahead for Key Milestones Amid Covid Vaccine Related Setback
The company is expected to receive marketing approval in the U.S. for its first immune globulin product next month and start commercialize...
Tina Banerjee
Follow
354 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.5
x